Kindex Therapeutics

Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the development of innovative cancer treatments. Through science and technology, the company strives to develop and commercialize products that address unmet medical needs, improve survival and have a favorable safety profile. Additionally, Dendreon develops therapeutic vaccines that stimulate the body's immune system to help fight cancer by targeting dendritic cells, which initiate an immune response to disease-causing antigens. The company also develops vaccines to treat breast, colorectal, lung, ovarian and uterine cancers along with monoclonal antibodies to fight blood cancers, such as non-Hodgkin's and B-cell lymphomas. Its partners include Japan's Kirin Brewery and Genentech. Dendreon Corporation is located in Seattle.

Omeros Corporation is a leading biopharmaceutical company based in Seattle, WA. With a focus on innovative and cutting-edge science, their world-class team has achieved scientific breakthroughs that have led to the development of wholly new classes of therapeutics, benefiting patients with challenging diseases and disorders. Their deep and diverse pipeline of small-molecule and protein therapeutics includes first-in-class drugs with new mechanisms of action, targeting previously untapped receptors and enzymes. The Omeros team is known for being exceptionally talented, passionate, collaborative, and diverse. They are committed to hiring smart, creative, and hard-working individuals from around the world who want to make a meaningful impact in the biopharmaceutical industry. Together, they strive to provide hope to patients and their families by delivering better outcomes and life-saving therapies.Generated from the website

Actx Inc, based in Seattle, WA, offers genomic services and personalized user experiences through their website. Users can access and use the services by accepting the terms of service, which outline legal rights and obligations. The company provides a non-exclusive license to access and use their materials, including data, software, and information, while also emphasizing the importance of privacy and feedback. Actx reserves the right to modify terms and conditions, requiring users to review and accept any changes to continue using their services.Generated from the website